301 related articles for article (PubMed ID: 36157456)
1. Fasting and stimulated glucagon-like peptide-1 exhibit a compensatory adaptive response in diabetes and pre-diabetes states: A multi-ethnic comparative study.
Chong SC; Sukor N; Robert SA; Ng KF; Kamaruddin NA
Front Endocrinol (Lausanne); 2022; 13():961432. PubMed ID: 36157456
[TBL] [Abstract][Full Text] [Related]
2. Impaired secretion of total glucagon-like peptide-1 in people with impaired fasting glucose combined impaired glucose tolerance.
Zhang F; Tang X; Cao H; Lü Q; Li N; Liu Y; Zhang X; Zhang Y; Cao M; Wan J; An Z; Tong N
Int J Med Sci; 2012; 9(7):574-81. PubMed ID: 22991496
[TBL] [Abstract][Full Text] [Related]
3. Impaired secretion of glucagon-like peptide 1 during oral glucose tolerance test in patients with newly diagnosed type 2 diabetes mellitus.
Wang XL; Ye F; Li J; Zhu LY; Feng G; Chang XY; Sun K
Saudi Med J; 2016 Jan; 37(1):48-54. PubMed ID: 26739974
[TBL] [Abstract][Full Text] [Related]
4. Plasma level of glucagon-like peptide 1 in obese Egyptians with normal and impaired glucose tolerance.
Hussein MS; Abushady MM; Refaat S; Ibrahim R
Arch Med Res; 2014 Jan; 45(1):58-62. PubMed ID: 24321596
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of islet beta cell function in subjects with normal glucose tolerance, impaired glucose regulation, and type 2 diabetes mellitus].
Liu J; Li YB; Shao H; Li YX; Yuan YH; Xiao YB; Weng JP
Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1252-5. PubMed ID: 17686259
[TBL] [Abstract][Full Text] [Related]
6. Mixed Meal and Intravenous L-Arginine Tests Both Stimulate Incretin Release Across Glucose Tolerance in Man: Lack of Correlation with β Cell Function.
Ruetten H; Gebauer M; Raymond RH; Calle RA; Cobelli C; Ghosh A; Robertson RP; Shankar SS; Staten MA; Stefanovski D; Vella A; Wright K; Fryburg DA;
Metab Syndr Relat Disord; 2018 Oct; 16(8):406-415. PubMed ID: 30117761
[TBL] [Abstract][Full Text] [Related]
7. Intact glucagon-like peptide-1 levels are not decreased in Japanese patients with type 2 diabetes.
Lee S; Yabe D; Nohtomi K; Takada M; Morita R; Seino Y; Hirano T
Endocr J; 2010; 57(2):119-26. PubMed ID: 19881250
[TBL] [Abstract][Full Text] [Related]
8. Metformin improves blood glucose by increasing incretins independent of changes in gluconeogenesis in youth with type 2 diabetes.
Cravalho CKL; Meyers AG; Mabundo LS; Courville A; Yang S; Cai H; Dai Y; Walter M; Walter PJ; Sharma S; Chacko S; Cogen F; Magge SN; Haymond MW; Chung ST
Diabetologia; 2020 Oct; 63(10):2194-2204. PubMed ID: 32728891
[TBL] [Abstract][Full Text] [Related]
9. Basal glucagon hypersecretion and response to oral glucose load in prediabetes and mild type 2 diabetes.
Ichikawa R; Takano K; Fujimoto K; Motomiya T; Kobayashi M; Kitamura T; Shichiri M
Endocr J; 2019 Aug; 66(8):663-675. PubMed ID: 31142688
[TBL] [Abstract][Full Text] [Related]
10. Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action.
Faerch K; Vaag A; Holst JJ; Glümer C; Pedersen O; Borch-Johnsen K
Diabetologia; 2008 May; 51(5):853-61. PubMed ID: 18317726
[TBL] [Abstract][Full Text] [Related]
11. Impact of incretin on early-phase insulin secretion and glucose excursion.
Shen J; Chen Z; Chen C; Zhu X; Han Y
Endocrine; 2013 Oct; 44(2):403-10. PubMed ID: 23283820
[TBL] [Abstract][Full Text] [Related]
12. [The changes of gastrointestinal hormones GLP-1, PYY and ghrelin in patients with newly diagnosed type 2 diabetes mellitus].
Cui T; Ren Y; Ma H; Liu SF; Zhang XX; Yu HL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):774-8. PubMed ID: 24325110
[TBL] [Abstract][Full Text] [Related]
13. Associations of β-cell function and insulin resistance with youth-onset type 2 diabetes and prediabetes among Asian Indians.
Mohan V; Amutha A; Ranjani H; Unnikrishnan R; Datta M; Anjana RM; Staimez L; Ali MK; Narayan KM
Diabetes Technol Ther; 2013 Apr; 15(4):315-22. PubMed ID: 23484483
[TBL] [Abstract][Full Text] [Related]
14. Glucagon-like peptide-1 secretion in women with gestational diabetes mellitus during and after pregnancy.
Lencioni C; Resi V; Romero F; Lupi R; Volpe L; Bertolotto A; Ghio A; Del Prato S; Marchetti P; Di Cianni G
J Endocrinol Invest; 2011 Oct; 34(9):e287-90. PubMed ID: 21666414
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of acute and extended infusions of glucagon-like peptide-1 on first- and second-phase insulin secretion in diabetic and nondiabetic humans.
Quddusi S; Vahl TP; Hanson K; Prigeon RL; D'Alessio DA
Diabetes Care; 2003 Mar; 26(3):791-8. PubMed ID: 12610039
[TBL] [Abstract][Full Text] [Related]
16. Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity.
Knop FK; Aaboe K; Vilsbøll T; Vølund A; Holst JJ; Krarup T; Madsbad S
Diabetes Obes Metab; 2012 Jun; 14(6):500-10. PubMed ID: 22171657
[TBL] [Abstract][Full Text] [Related]
17. Effects of Gender-Affirming Hormone Therapy on Insulin Sensitivity and Incretin Responses in Transgender People.
Shadid S; Abosi-Appeadu K; De Maertelaere AS; Defreyne J; Veldeman L; Holst JJ; Lapauw B; Vilsbøll T; T'Sjoen G
Diabetes Care; 2020 Feb; 43(2):411-417. PubMed ID: 31740479
[TBL] [Abstract][Full Text] [Related]
18. Altered Plasma Levels of Glucagon, GLP-1 and Glicentin During OGTT in Adolescents With Obesity and Type 2 Diabetes.
Manell H; Staaf J; Manukyan L; Kristinsson H; Cen J; Stenlid R; Ciba I; Forslund A; Bergsten P
J Clin Endocrinol Metab; 2016 Mar; 101(3):1181-9. PubMed ID: 26745255
[TBL] [Abstract][Full Text] [Related]
19. Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response.
Tura A; Bagger JI; Ferrannini E; Holst JJ; Knop FK; Vilsbøll T; Mari A
Nutr Metab Cardiovasc Dis; 2017 Dec; 27(12):1123-1129. PubMed ID: 29162361
[TBL] [Abstract][Full Text] [Related]
20. Older Subjects With β-Cell Dysfunction Have an Accentuated Incretin Release.
de Jesús Garduno-Garcia J; Gastaldelli A; DeFronzo RA; Lertwattanarak R; Holst JJ; Musi N
J Clin Endocrinol Metab; 2018 Jul; 103(7):2613-2619. PubMed ID: 29672742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
